Publications by authors named "Kathleen A Doan"

Objective: To evaluate the use of recombinant factor VIIa (rFVIIa) for the treatment of bleeding in nonhemophiliac children.

Methods: This was a retrospective chart review of all patients < 18 years of age who received rFVIIa over a 2 year period.

Results: Twenty-four pediatric patients received a total of 240 doses of rFVIIa for treatment of bleeding.

View Article and Find Full Text PDF